8 completed, 2 terminated, 2 withdrawn, 1 active not recruiting. 7 Phase 2, 6 Phase 3, 3 Phase 4, 1 Not applicable, 1 Phase 1.
Follow Privigen: new trials by email Literature Review of Privigen trials Research Report on Privigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IVIG in Painful Sensory Neuropathy Intravenous immunoglobulin, Placebo - Sensory Neuropathy, Small Fiber Neuropathy | Phase 4 | Not yet recruiting | Sorlandet Hospital HF | 20 | 2024-02-01 | 2023-12-27 |
| rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) Privigen, Thymoglobulin, Plasma Exchange - Kidney Transplantation | Phase 3 | Completed | Institute for Clinical and Experimental Medicine | 17 | 2020-07-27 | 2024-08-15 |
| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus Rituximab, IVIg - Pemphigus | Phase 2 | Active not recruiting | The University of Hong Kong | 20 | 2020-06-20 | 2025-07-08 |
| Autologous Transplant To End NMO Spectrum Disorder Rituximab, Cyclophosphamide, Mesna - Neuromyelitis Optica, Devic's Disease | Phase 2 / Phase 3 | Withdrawn | Northwestern University | 2019-11-01 | 2019-11-20 | |
| Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc) IgPro20, IgPro10 - Diffuse Cutaneous Systemic Sclerosis | Phase 2 | Completed | CSL Behring | 27 | 2019-09-19 | 2024-02-05 |
| Two Dose Levels of Privigen in Pediatric CIDP IgPro10 - Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase 4 | Recruiting | CSL Behring | 30 | 2019-02-28 | 2026-06-01 |
| Cardiac Safe Transplants for Systemic Sclerosis Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma | Phase 2 / Phase 3 | Terminated | Northwestern University | 9 | 2018-05-17 | 2020-08-12 |
| Maximizing Outcome of Multiple Sclerosis Transplantation Cyclophosphamide, Mesna, rATG - Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Terminated | Northwestern University | 66 | 2017-11-08 | 2021-01-11 |
| Ig PRx in AECOPD: Pilot Study Intravenous immunoglobulin (IVIG), Normal Saline - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Ottawa Hospital Research Institute | 48 | 2016-09-01 | 2019-11-27 |
| Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis Immunoglobulins, Intravenous (Privigen), Placebo - Encephalitis | Phase 3 | Completed | University of Oxford | 18 | 2016-01-01 | 2024-03-04 |
| Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis | Phase 2 | Completed | Anders Perner | 100 | 2014-04-01 | 2016-09-30 |
| IVIG Treatment in Systemic Sclerosis Privigen - Systemic Sclerosis, Diffuse Scleroderma | Not applicable | Unknown | Georgetown University | 14 | 2013-04-01 | 2018-07-17 |
| IVIG in Acute Ischemic Stroke: A Pilot Study Privigen, Normal Saline - Ischemic Stroke | Phase 1 | Withdrawn | Inova Health Care Services | 2013-03-01 | 2013-11-11 | |
| A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) IgPro10 - Immune Thrombocytopenic Purpura | Phase 4 | Completed | CSL Behring | 57 | 2011-11-01 | 2016-04-08 |
| Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins intravenous immunoglobulin (IVIg) - Multiple System Atrophy | Phase 2 | Completed | University of Massachusetts, Worcester | 9 | 2008-06-01 | 2017-02-23 |
| Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 Immunoglobulin Intravenous (Human) - Immune Thrombocytopenic Purpura | Phase 3 | Completed | CSL Behring | 58 | 2004-12-01 | 2011-11-23 |
Scleroderma, Diffuse (3) · Purpura, Thrombocytopenic, Idiopathic (2) · Scleroderma, Systemic (2) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Encephalitis (1) · Encephalomyelitis (1) · Fasciitis, Necrotizing (1) · Fournier Gangrene (1) · Gas Gangrene (1) · Ischemic Stroke (1) · Meningoencephalitis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Multiple System Atrophy (1) · Nervous System Diseases (1)
CSL Behring (4) · Northwestern University (3) · Anders Perner (1) · Georgetown University (1) · Inova Health Care Services (1) · Institute for Clinical and Experimental Medicine (1) · Ottawa Hospital Research Institute (1) · Sorlandet Hospital HF (1) · The University of Hong Kong (1) · University of Massachusetts, Worcester (1) · University of Oxford (1)
United States (7) · United Kingdom (3) · Germany (2) · Italy (2) · Poland (2) · Australia (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · Hong Kong (1) · Romania (1) · Russia (1) · Serbia (1) · Ukraine (1)
Richard Burt, MD (3) · Anders Perner, Professor (1) · Andrew J Pollard, FRCPCH, PhD (1) · Beverly C Walters, MD (1) · Jack Cochran, MD (1) · Juthaporn Cowan, MD, PhD, FRCPC (1) · Milan Basta, MD (1) · Ondrej Viklicky, Prof. (1) · Othmar Zenker, MD (1) · Peter Novak, MD, PhD (1) · Sze Man Wong, MBBS (1) · Virginia D Steen, MD (1)
PMID 19635187, PMID 23116538, PMID 27399982, PMID 28421246, PMID 30116551, PMID 31916575, PMID 32612255, PMID 34887657, PMID 37945292, PMID 38353301, PMID 39909490, PMID 40458542
2018 (2), 2004 (1)